May is Women’s Health Month and in observation, Bio.News sat down with Ragasudha Botta, MBBS, PhD, MMSc, Senior Scientific Director, Critical Path for Parkinson’s […]
Recent medical breakthroughs are enabling better diagnostics for prostate cancer and Alzheimer’s and improving real-time imaging of tumors during surgery. The researchers behind these
Bayh-Dole Coalition report highlights eight American Innovators Read More »
May is both Lupus Awareness Month and Women’s Health Month. And the timing is apropos as lupus affects female patients at a far higher
Lupus Awareness Month meets Women’s Health Month: Advancing care, research, and advocacy Read More »
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026 Read More »
“We’re finding that the most disruptive pieces of legislation are much more likely to advance in state legislatures first, before eventually gaining traction at
State of play: BIO Coffee Chat covers how state policies impact access Read More »
The BIO International Convention, the world’s largest annual gathering of biotechnology stakeholders, provides an exceptional opportunity to make the connections that enable development of
Experts explain how to drive business development with BIO 2026 Read More »
Key takeaway: PDUFA enables the FDA to collect user fees from the biopharmaceutical industry, allowing for efficient and more predictable reviews. This funding model
What is PDUFA—and why does it matter for biotech innovators, FDA & patients? Read More »
Ohio’s diverse biotech sector provides the state with employment for 65,000 and provides the world with medical breakthroughs. Of the first eight gene therapies
BIO on the American Road tours gene therapy hub in Ohio Read More »
Advancing innovation in the women’s health space has long been an uphill battle. But a number of leaders in the biotech community have taken
BIO panel at HERS explores women’s health biotech ecosystem Read More »
When a biotech firm sells investors on the promise of a new drug, what they are really selling is the intellectual property behind their
BIO is expanding its work to defend IP Read More »
